foxo4-dri senolytic peptide human trial alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice Molecular modelling of the FOXO4-TP53
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9





























